Globant SAGLOB
Price$36.98Intrinsic value$67.0781% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2.5B+1.6% YoYTTM through 31 Dec 2025
Net Income $104M-38.5% YoYTTM through 31 Dec 2025
Free Cash Flow $282MTTM through 31 Dec 2025

Margins

Current
Gross Margin35.0%
Operating Margin7.0%
Net Margin4.2%

Returns

4.8%ROE
3.1%ROA
4.6%ROIC

Balance Sheet Health

Debt / Equity0.17x
Current Ratio1.64x
Net Debt$116.4M
Cash & Equivalents$243.7M

Quality Metrics

Piotroski F-Score3 / 9
FCF Margin11.5%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $2.5B
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $2.29

Dividend

No dividend

Capital Allocation

Capex Intensity0.8%

Segment Performance

No segment data available.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.